Our Companies | Catalyze Partners

Almaden Genomics

CATALYZE LAUNCH: 2022

MARKETS SERVED: Biotech research and pharma drug discovery

MARKETS SIZE & GROWTH: $10B by 2028 at 16.3% CAGR

IP SOURCED FROM: IBM

TECHNOLOGY: SaaS

Almaden Genomics offers g.nome™, a cloud-native SaaS platform that accelerates genomic research and biotech development, and enables progress toward the full potential of precision medicine. Originally an internal startup within IBM’s Almaden Research Center in Silicon Valley, Almaden Genomics has emerged as an independent company under the guidance of Catalyze Partners to commercialize the technology globally.

View Company Website

Alpine Advanced Materials

CATALYZE LAUNCH: 2019

MARKETS SERVED: Aerospace, Defense, Space, Energy, Emerging Transportation

MARKETS SIZE & GROWTH: $276B by 2030 at 8.2% CAGR

IP SOURCED FROM: Lockheed Martin

TECHNOLOGY: Advanced Materials

Alpine Advanced Materials is a leading expert in the design and manufacturing of custom-engineered parts for the world’s most demanding applications. With experience across multiple industries, a collaborative approach, and deep expertise in designing manufacturing and rapid prototyping, Alpine helps customers deliver the future of innovation.

View Company Website

Metro Aerospace

CATALYZE LAUNCH: 2017

MARKETS SERVED: Defense Transport and Commercial Aircraft

TRACTION: ROI of 2X in First Year of Operation

IP SOURCED FROM: Lockheed Martin

TECHNOLOGY: Drag-Reduction

Metro Aerospace is accelerating innovation to shape the future of military and commercial aerospace by way of next-generation drag-reduction. Metro manufactures Microvanes™, which are small, 3D printed aerodynamic components that are surface-mounted on the fuselage of an aircraft to effectively reshape tail section airflow, reducing overall drag and fuel consumption.

View Company Website